Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Proteogenomic characterization of pancreatic ductal adenocarcinoma

Cell(2021)10.1016/j.cell.2021.08.023Source: DataRank Database

Proteogenomic characterization of pancreatic ductal adenocarcinoma is a research paper published in Cell (2021). On theSindex it has a DataRank of 7.9. It has been cited 606 times, with 200 citing works in its 1-hop citation network.

N/A

7.9DataRank · unranked

Scored on demand from live citation data

Open Access606 citations · 200 citing works in its network

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (13 grants)OA: hybridIDs (PubMed)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 12%Citation Network 88%

Base Score Contribution

0.961

From this paper's citation signal

Citation Network Contribution

6.9

From 200 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 200 citers.

Prognostic factors of pancreatic tumors in children and adolescents: a population study based on the surveillance, epidemiology, and end results database
BMC Gastroenterology202414 citations21 referencesContributes 0.129
Comparative N-Glycoproteomics Analysis of Clinical Samples Via Different Mass Spectrometry Dissociation Methods
Frontiers in Chemistry202231 citations36 referencesContributes 0.096
Comprehensive proteomic signature and identification of CDKN2A as a promising prognostic biomarker and therapeutic target of colorectal cancer
World Journal of Clinical Cases202225 citations34 referencesContributes 0.096
Modulation of cellular metabolism by protein crotonylation regulates pancreatic cancer progression
Cell Reports202362 citations44 referencesContributes 0.094
Hepatobiliary Tumor Organoids Reveal HLA Class I Neoantigen Landscape and Antitumoral Activity of Neoantigen Peptide Enhanced with Immune Checkpoint Inhibitors
Advanced Science202272 citations46 referencesContributes 0.093

Authors (100)

Chen Huang ORCID,Daniel Cui Zhou ORCID,Yingwei Hu ORCID,T. Mamie Lih ORCID,Sara R. Savage ORCID

Live enrichment

PubMed:21097893

National Institutes of Health

Grant: U01CA214114

National Institutes of Health

Grant: U24CA210955

National Institutes of Health

Grant: U24CA210986

National Institutes of Health

Grant: U24CA210972

National Institutes of Health

Grant: U24CA210967

National Institutes of Health

Grant: U24CA210954

National Institutes of Health

Grant: U01CA214125

National Institutes of Health

Grant: U24CA210985

National Institutes of Health

Grant: U24CA210979

National Institutes of Health

Grant: U01CA214116

National Institutes of Health

Grant: U24CA210993

National Institutes of Health

Grant: P30ES017885

National Institutes of Health

Grant: P30CA008748

hybridLicense: cc-by

publisherhttps://doi.org/10.1016/j.cell.2021.08.023

publisherhttps://api.elsevier.com/content/article/PII:S0092867421009971?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0092867421009971?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8654574

Related Papers (10)

A proteogenomic portrait of lung squamous cell carcinoma

N/A

7.2DataRank · unranked

Cell(2021)

co-citedsame journal

10.1016/j.cell.2021.07.016

Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma

N/A

9.1DataRank · unranked

Cell(2020)

co-citedsame journal

10.1016/j.cell.2020.06.013

Proteogenomic and metabolomic characterization of human glioblastoma

N/A

8.7DataRank · unranked

Cancer Cell(2021)

co-cited

10.1016/j.ccell.2021.01.006

Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy

N/A

8.1DataRank · unranked

Cell(2020)

co-citedsame journal

10.1016/j.cell.2020.10.036

Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer

N/A

0.878DataRank · unranked

Cell(2020)

co-citedsame journal

10.1016/j.cell.2020.10.044

Quantitative Proteomics of the Cancer Cell Line Encyclopedia

Top 3%

5.9DataRank

Cell(2020)

co-citedsame journal

10.1016/j.cell.2019.12.023

Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer

N/A

2.5DataRank · unranked

Cancer Discovery(2022)

co-cited

10.1158/2159-8290.cd-22-0200

Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness

N/A

3.6DataRank · unranked

Cancer Cell(2022)

co-cited

10.1016/j.ccell.2022.12.001

Deep Visual Proteomics defines single-cell identity and heterogeneity

N/A

10.4DataRank · unranked

Nature Biotechnology(2022)

co-cited

10.1038/s41587-022-01302-5

UniProt: the Universal Protein Knowledgebase in 2023

Top 2%

7.8DataRank

Nucleic Acids Research(2022)

co-cited

10.1093/nar/gkac1052